FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to clinical immunology and aims at patient-specific immunotherapy. That is ensured by the use in a nidus zone of supernatant of stimulated autologous leukocytes with the concentration of neutrophilic antimicrobial peptides in supernatant not less than 2000 pg/ml. Supernatant is administered in applications and/or subcutaneously, or submucosally, or in instillations for 5-10 days.
EFFECT: method provides prevention of secondary immunodeficiency, reduced inflammation, wound decontamination, stimulated repair, allows lower dosages and period of administering antibiotics, due to joint action of a complex of cytokines and antimicrobial neutrophilic peptides produced by autologous leukocytes.
6 cl, 3 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ENDOSCOPIC TRANSLUMINAL TREATMENT OF INFECTED PANCREATONECROSIS | 2020 |
|
RU2739666C1 |
| METHOD OF TREATING ANGINA ACUTA (ACUTE TONSILLITIS) | 2011 |
|
RU2456986C1 |
| METHOD OF TREATING CHRONIC ADENOIDITIS AND TONSILLITIS IN CHILDREN | 2009 |
|
RU2391108C1 |
| METHOD FOR PREVENTION OF WOUND COMPLICATIONS IN ABDOMINOPLASTY | 2012 |
|
RU2491101C1 |
| METHOD OF ANTITUMOUR IMMUNOTHERAPY | 2012 |
|
RU2530523C2 |
| METHOD OF PREVENTING WOUND COMPLICATIONS AFTER PROSTHETIC HERNIOPLASTY IN CASE OF INFRINGEMENT OF VENTRAL HERNIAS | 2011 |
|
RU2455947C1 |
| METHOD FOR TREATMENT OF CHRONIC TONSILLITIS | 2003 |
|
RU2240132C1 |
| METHOD OF TREATING CHRONIC TONSILLITIS ACCOMPANYING CHRONIC OPISTHORCHIASIS | 2023 |
|
RU2817977C1 |
| METHOD FOR PREVENTION OF WOUND COMPLICATIONS FOLLOWING REPLACING INGUINAL HERNIOPLASTY | 2011 |
|
RU2469654C1 |
| AGENT FOR APPLYING ORAL AND NASAL CAVITIES AND METHOD FOR ITS USE AS PART OF COMPLEX THERAPY OF INFECTIOUS AND INFLAMMATORY DISEASES OF NASAL AND ORAL CAVITIES | 2021 |
|
RU2762506C1 |
